Polskie Radio takes up the question of how well oral Ozempic holds up for weight loss. Little detail is given beyond the topic itself.
Recap by typeshit. Full story at www.polskieradio.pl.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
A short item claims a newer group of weight loss drugs beats Ozempic, without naming the drugs or the data behind the claim.
Loading…